MedPath

the effect of buprenorphine and methadone in the reduction of methamphetamine craving

Not Applicable
Conditions
Methamphetamine Dependency.
Mental and behavioural disorders due to use of other stimulants, including caffeine
Registration Number
IRCT2015112125160N1
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
40
Inclusion Criteria

Age: 18-50 ;informed consent; methamphetamine dependence
Exclusion criteria:Patients unwilling to participate at beginning or during the study; use of another substance except Methamphetamine as of the main substance.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Craving. Timepoint: daily for 14 days. Method of measurement: questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath